Literature DB >> 20307196

p16 Modulates VEGF expression via its interaction with HIF-1alpha in breast cancer cells.

Jun Zhang1, Andrew Lu, Liyuan Li, Junming Yue, Yi Lu.   

Abstract

The degree of tumor progression (such as growth, angiogenesis, and metastasis) directly correlates with the expression of vascular endothelial growth factor (VEGF), but inversely correlates with the expression of tumor-suppressor gene p16, therefore we examined whether the restoration of p16 in breast cancer cells would modulate VEGF expression. Adenoviral-mediated p16 expression downregulated VEGF gene expression in breast cancer cells, and inhibited breast cancer cell-induced angiogenesis by a dorsal air sac model in mice. Moreover, p16 appears to form a complex with HIF-1a, the transcription factor for the VEGF gene promoter. Taken together, the binding between p16 and HIF-1a protein may alter HIF-1a's ability to transactivate VEGF expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307196      PMCID: PMC2881182          DOI: 10.3109/07357900903286941

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  42 in total

Review 1.  Hydroxylation of HIF-1: oxygen sensing at the molecular level.

Authors:  Gregg L Semenza
Journal:  Physiology (Bethesda)       Date:  2004-08

Review 2.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

3.  Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas.

Authors:  M Detmar; P Velasco; L Richard; K P Claffey; M Streit; L Riccardi; M Skobe; L F Brown
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

4.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

5.  Induction of cyclin-dependent kinase inhibitors and G(1) prolongation by the chemopreventive agent N-acetylcysteine.

Authors:  M Liu; N M Wikonkal; D E Brash
Journal:  Carcinogenesis       Date:  1999-09       Impact factor: 4.944

6.  Angiostatin induces and sustains dormancy of human primary tumors in mice.

Authors:  M S O'Reilly; L Holmgren; C Chen; J Folkman
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

7.  2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

Authors:  Nicola J Mabjeesh; Daniel Escuin; Theresa M LaVallee; Victor S Pribluda; Glenn M Swartz; Michelle S Johnson; Margaret T Willard; Hua Zhong; Jonathan W Simons; Paraskevi Giannakakou
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

8.  Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

Authors:  Toru Hiraga; Shinae Kizaka-Kondoh; Kiichi Hirota; Masahiro Hiraoka; Toshiyuki Yoneda
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

Review 9.  Hypoxia-driven selection of the metastatic phenotype.

Authors:  Richard Sullivan; Charles H Graham
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

10.  Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma.

Authors:  Rob A Cairns; Richard P Hill
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

View more
  16 in total

1.  A compendium of proteins that interact with HIF-1α.

Authors:  Gregg L Semenza
Journal:  Exp Cell Res       Date:  2017-03-20       Impact factor: 3.905

2.  Loss of ARF/INK4A Promotes Liver Progenitor Cell Transformation Toward Tumorigenicity Supporting Their Role in Hepatocarcinogenesis.

Authors:  Robyn P Strauss; Katherine M Audsley; Adam M Passman; Joanne H van Vuuren; Megan L Finch-Edmondson; Bernard A Callus; George C Yeoh
Journal:  Gene Expr       Date:  2020-04-21

3.  p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade.

Authors:  David P Molkentine; Jessica M Molkentine; Kathleen A Bridges; David R Valdecanas; Annika Dhawan; Reshub Bahri; Andrew J Hefner; Manish Kumar; Liangpeng Yang; Mohamed Abdelhakiem; Phillip M Pifer; Vlad Sandulache; Aakash Sheth; Beth M Beadle; Howard D Thames; Kathryn A Mason; Curtis R Pickering; Raymond E Meyn; Heath D Skinner
Journal:  Cancer Res       Date:  2022-03-01       Impact factor: 13.312

4.  Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells.

Authors:  Liyuan Li; Yi Lu
Journal:  J Cancer       Date:  2010-09-01       Impact factor: 4.207

5.  Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents.

Authors:  Jiyoung Mun; Adnan Abdul Jabbar; Narra Sarojini Devi; Shaoman Yin; Yingzhe Wang; Chalet Tan; Deborah Culver; James P Snyder; Erwin G Van Meir; Mark M Goodman
Journal:  J Med Chem       Date:  2012-07-24       Impact factor: 7.446

6.  Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression.

Authors:  Renzo G DiNatale; Alejandro Sanchez; A Ari Hakimi; Ed Reznik; Julian Marcon; Ritesh R Kotecha; Sounak Gupta; Fengshen Kuo; Vladimir Makarov; Amar Sandhu; Roy Mano; Andrew W Silagy; Kyle A Blum; Daniel E Nassau; Nicole E Benfante; Michael V Ortiz; Maria I Carlo; Timothy A Chan; Robert J Motzer; Martin H Voss; Jonathan Coleman; Paul Russo; Victor Reuter
Journal:  Clin Cancer Res       Date:  2020-03-27       Impact factor: 12.531

7.  Optimizing a 3D Culture System to Study the Interaction between Epithelial Breast Cancer and Its Surrounding Fibroblasts.

Authors:  Liyuan Li; Yi Lu
Journal:  J Cancer       Date:  2011-08-25       Impact factor: 4.207

8.  Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.

Authors:  German Reyes-Botero; Caroline Dehais; Ahmed Idbaih; Nadine Martin-Duverneuil; Marion Lahutte; Catherine Carpentier; Eric Letouzé; Olivier Chinot; Hugues Loiseau; Jerome Honnorat; Carole Ramirez; Elisabeth Moyal; Dominique Figarella-Branger; François Ducray
Journal:  Neuro Oncol       Date:  2013-12-18       Impact factor: 13.029

9.  The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer.

Authors:  Emmi Peurala; Peppi Koivunen; Kirsi-Maria Haapasaari; Risto Bloigu; Arja Jukkola-Vuorinen
Journal:  Breast Cancer Res       Date:  2013-01-21       Impact factor: 6.466

10.  Inhibition of Breast Tumor Cell Growth by Ectopic Expression of p16/INK4A Via Combined Effects of Cell Cycle Arrest, Senescence and Apoptotic Induction, and Angiogenesis Inhibition.

Authors:  Yi Lu; Xiongwen Zhang; Jun Zhang
Journal:  J Cancer       Date:  2012-08-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.